Cargando…

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection

BACKGROUND: CD133 was detected in several types of cancers including hepatocellular carcinoma (HCC), which raised the possibility of stem cell origin in a subset of cancers. However, reappearance of embryonic markers in de-differentiated malignant cells was commonly observed. It remained to be eluci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Chau-Ting, Kuo, Chia-Jung, Lai, Ming-Wei, Chen, Tse-Ching, Lin, Chun-Yen, Yeh, Ta-Sen, Lee, Wei-Chen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753636/ https://www.ncbi.nlm.nih.gov/pubmed/19744348 http://dx.doi.org/10.1186/1471-2407-9-324

Ejemplares similares

Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma
por: Chang, Ming-Ling, et al.
Publicado: (2013)

Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
por: Huang, Shiu‐Feng, et al.
Publicado: (2018)

Peritumoral Small EphrinA5 Isoform Level Predicts the Postoperative Survival in Hepatocellular Carcinoma
por: Wang, Tong-Hong, et al.
Publicado: (2012)

Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma
por: LE, PUO-HSIEN, et al.
Publicado: (2014)

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
por: Chen, Wei-Ching, et al.
Publicado: (2015)

Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B
por: Yeh, Chau-Ting, et al.
Publicado: (2011)

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
por: Lai, Ming-Wei, et al.
Publicado: (2019)

Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma
por: Huang, Ya-Hui, et al.
Publicado: (2012)

Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports
por: Lai, Ming-Wei, et al.
Publicado: (2010)

Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy
por: Lin, Chih-Lang, et al.
Publicado: (2023)

Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy
por: Wang, Tong-Hong, et al.
Publicado: (2015)

Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma
por: Huang, Shu-Wei, et al.
Publicado: (2021)

CD133 Targeted PVP/PMMA Microparticle Incorporating Levamisole for the Treatment of Ovarian Cancer
por: Wang, Yu-Chi, et al.
Publicado: (2020)

The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
por: Chen, Yao-Li, et al.
Publicado: (2017)

Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth
por: LIN, WEY-RAN, et al.
Publicado: (2012)

Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area
por: Hu, Jing-Hong, et al.
Publicado: (2016)

Large Fragment Pre-S Deletion and High Viral Load Independently Predict Hepatitis B Relapse after Liver Transplantation
por: Wu, Ting-Jung, et al.
Publicado: (2012)

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma
por: ZHUANG, HUI-WEN, et al.
Publicado: (2013)

Bone Densities Assessed by Hounsfield Units at L5 in Computed Tomography Image Independently Predict Hepatocellular Carcinoma Development in Cirrhotic Patients
por: Yeh, Christopher, et al.
Publicado: (2022)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity
por: Lin, Gigin, et al.
Publicado: (2018)

Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question
por: Lai, Bo-Ru, et al.
Publicado: (2016)

Label-free quantitative proteomics of CD133-positive liver cancer stem cells
por: Tsai, Sheng-Ta, et al.
Publicado: (2012)

Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition
por: Wang, Tong-Hong, et al.
Publicado: (2015)

Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area
por: Ungtrakul, Teerapat, et al.
Publicado: (2016)

Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
por: Lai, Ming-Wei, et al.
Publicado: (2022)

CD133(+) cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2017)

A proposal for T1 subclassification in hepatocellular carcinoma: reappraisal of the AJCC 8th edition
por: Lee, Chao-Wei, et al.
Publicado: (2022)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

Absence of asymptomatic malaria in a cohort of 133 individuals in a malaria endemic area of Assam, India
por: Dhiman, Sunil, et al.
Publicado: (2015)

Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi
por: Lai, Ming-Wei, et al.
Publicado: (2020)

Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody
por: Lai, Ming-Wei, et al.
Publicado: (2016)

Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition
por: Wang, Tong-Hong, et al.
Publicado: (2016)

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C
por: Yeh, Ming-Lun, et al.
Publicado: (2018)

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma
por: Yeh, Ming-Lun, et al.
Publicado: (2017)

Effects of sex and generation on hepatitis B viral load in families with hepatocellular carcinoma
por: Hsieh, Ai-Ru, et al.
Publicado: (2017)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Identification of Transforming Hepatitis B Virus S Gene Nonsense Mutations Derived from Freely Replicative Viruses in Hepatocellular Carcinoma
por: Huang, Shiu-Feng, et al.
Publicado: (2014)

Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area
por: Bae, So Young, et al.
Publicado: (2012)

TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma †
por: Lin, Yang-Hsiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_heo4iu21fgft1s23eteaaffh0t